Delivery Order SPE2DB22D1106-SPE2DB23FEYA1
Award Date 9/6/23
Potential Completion Date 9/7/23
Potential Value $62K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at $27,217.56, is for the delivery of the drug Biktarvy 50-200-25 mg tablet. It is a firm fixed-price delivery order contract, with an ultimate completion date of December 6, 2021. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that plays a critical role in supplying medical products to federal government agencies,...
- This federal contract award is a delivery order from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $33,900.29 firm fixed-price contract is for the delivery of Biktarvy 50-200-25 mg tablet units, with a performance period ending on October 19, 2023. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that plays a critical role in supplying medical products to...
- This federal contract award, valued at $23,714.66, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Biktarvy 50-200-25 mg tablets. It is a firm-fixed-price delivery order with a completion date of February 6, 2024. The contract was awarded on February 5, 2024, and there was no set-aside designation used. Amerisourcebergen Drug Corp holds a significant...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract, valued at $74,541.51, is for the delivery of Biktarvy 50-200-25 mg tablets, a specialty pharmaceutical product. The contract is a Firm Fixed Price Delivery Order, with an ultimate completion date of May 11, 2023. This award is not designated as a set-aside contract. Amerisourcebergen Drug Corp is a major pharmaceutical...
- This federal contract award, valued at $24,575.66, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Biktarvy 50-200-25 MG Tablet in 30-count packages. This is a firm-fixed-price delivery order with a completion date of December 7, 2023. The contract has no set-aside designation, indicating it was awarded through full and open competition. Amerisourcebergen Drug Corp is a major pharmaceutical...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $10,704.06 firm fixed-price delivery order is for the supply of Biktarvy 50-200-25 mg tablets. This award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00, which provides a comprehensive range of pharmaceutical products and medical supplies to support military treatment facilities, veterans' healthcare programs, and...
- This federal contract award, valued at $31,541.00, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Biktarvy, a 50-200-25 mg tablet, to support U.S. government healthcare requirements. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of April 12, 2023. It is not designated as a set-aside contract. Amerisourcebergen Drug Corp is the prime contractor and holds a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The award, valued at $92,806.78, is for the delivery of Biktarvy 50-200-25 mg tablets, a pharmaceutical product. The contract is a Firm Fixed Price delivery order that does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp, a major pharmaceutical distributor, holds a significant...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company and subsidiary of Cencora, Inc. The contract, valued at $144,534.13, is a delivery order for the supply of Biktarvy 50-200-25 mg tablets. It has a completion date of December 12, 2022 and is a firm fixed-price contract. The contract is not designated with a set-aside requirement, indicating open competition. Amerisourcebergen Drug Corp holds a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $14,200.61 delivery order is for the supply of Biktarvy 50-200-25 mg tablets, a specialty medication. The contract has an ultimate completion date of March 24, 2022. Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a critical vendor for federal healthcare programs, particularly within military and...